These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18446262)

  • 1. The Janus-face kynurenic acid.
    Rózsa E; Robotka H; Vécsei L; Toldi J
    J Neural Transm (Vienna); 2008 Aug; 115(8):1087-91. PubMed ID: 18446262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel kynurenic acid analogue: a comparison with kynurenic acid. An in vitro electrophysiological study.
    Marosi M; Nagy D; Farkas T; Kis Z; Rózsa E; Robotka H; Fülöp F; Vécsei L; Toldi J
    J Neural Transm (Vienna); 2010 Feb; 117(2):183-8. PubMed ID: 19953278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro.
    Scharfman HE; Goodman JH
    Neuroscience; 1998 Oct; 86(3):751-64. PubMed ID: 9692715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenic acid has a dual action on AMPA receptor responses.
    Prescott C; Weeks AM; Staley KJ; Partin KM
    Neurosci Lett; 2006 Jul; 402(1-2):108-12. PubMed ID: 16644124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.
    Stone TW
    Eur J Neurosci; 2007 May; 25(9):2656-65. PubMed ID: 17459105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
    Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J
    Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-N-methyl-D-aspartate receptors mediating synaptic transmission in the avian cochlear nucleus: effects of kynurenic acid, dipicolinic acid and streptomycin.
    Jackson H; Nemeth EF; Parks TN
    Neuroscience; 1985 Sep; 16(1):171-9. PubMed ID: 3012407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxykynurenic acid and kynurenic acid differently antagonise AMPA and NMDA receptors in hippocampal neurones.
    Weber M; Dietrich D; Gräsel I; Reuter G; Seifert G; Steinhäuser C
    J Neurochem; 2001 May; 77(4):1108-15. PubMed ID: 11359876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-serine relieves chronic lead exposure-impaired long-term potentiation in the CA1 region of the rat hippocampus in vitro.
    Sun H; Wang HL; Wang S
    Neurosci Lett; 2007 May; 417(2):118-22. PubMed ID: 17408856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo.
    Perkins MN; Stone TW
    Exp Neurol; 1985 Jun; 88(3):570-9. PubMed ID: 2987017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
    Suárez LM; Solís JM
    Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schild plot analysis of glycine and kynurenic acid at the N-methyl-D-aspartate excitatory amino acid receptor.
    Pullan LM; Cler JA
    Brain Res; 1989 Sep; 497(1):59-63. PubMed ID: 2551451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices.
    Scharfman HE; Hodgkins PS; Lee SC; Schwarcz R
    Neurosci Lett; 1999 Oct; 274(2):111-4. PubMed ID: 10553950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine.
    Bespalov A; Dumpis M; Piotrovsky L; Zvartau E
    Eur J Pharmacol; 1994 Nov; 264(3):233-9. PubMed ID: 7698160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High potency of the orally-active NMDA-receptor antagonist CGP 40 116 in inhibiting excitatory postsynaptic potentials of rat basolateral amygdala neurones in vitro.
    Ferry B; Magistretti PJ; Pralong E
    Neuropharmacology; 1997; 36(11-12):1555-9. PubMed ID: 9517426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation by glycine, Mg2+ and polyamines of the N-methyl-D-aspartate-induced locomotion in the neonatal rat spinal cord in vitro.
    Bertrand S; Cazalets JR
    Neuroscience; 1999; 94(4):1199-206. PubMed ID: 10625059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Evaluation and Electrophysiological Effects of Some Kynurenic Acid Analogs.
    Fehér E; Szatmári I; Dudás T; Zalatnai A; Farkas T; Lőrinczi B; Fülöp F; Vécsei L; Toldi J
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.